2012 annual financial data
Dyne Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,466.67%.
Operating income was 714,000,000 USD and net income was 87,000,000 USD.
Operating cash flow was -44,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- 714,000,000 USD
- Net income
- 87,000,000 USD
- Operating cash flow
- -44,000,000 USD